We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
-$36M
(-19%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-30.71%
Top 10 Holdings %
Top 10 Hldgs %
41.15%
Holding
341
New
79
Increased
30
Reduced
42
Closed
62
Avg Time Held Equity + Options
3.4
quarters
Top 10 Avg Time Held Equity + Options
1.8
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
2.9
quarters
Top 20 Avg Time Held Equity only
3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.19M |
| 2 |
LL Flooring Holdings, Inc.
LL
|
+$1.02M |
| 3 |
McDonald's
MCD
|
+$949K |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$869K |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$845K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.08M |
| 2 |
Esperion Therapeutics
ESPR
|
+$1.61M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$1.07M |
| 4 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.06M |
| 5 |
Loews
L
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.42% |
| 2 | Miscellaneous | 30.29% |
| 3 | Healthcare | 15.66% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Technology | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bank of America
BAC
$381B
| $38.6M | 25.75% |
2,507,548
-17,000
| -0.7% | -$273K |
2013 Q2
7 quarters
|
|
2
CALL
IBM
IBM
$213B
| $4.82M | 3.21% |
+31,380
| New | +$4.76M |
2015 Q1
0 quarters
|
|
|
3
CALL
McDonald's
MCD
$166B
| $2.92M | 1.95% |
30,000
+15,000
| +100% | +$1.42M |
2014 Q3
2 quarters
|
|
4
CALL
Johnson & Johnson
JNJ
$634B
| $2.52M | 1.68% |
25,000
| – | – |
2014 Q2
3 quarters
|
|
|
ARIA
5
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.47M | 1.65% |
300,100
+7,900
| +3% | +$58.4K |
2013 Q4
5 quarters
|
|
6
DELISTED
Denny's
DENN
| $2.39M | 1.6% |
210,000
-10,000
| -5% | -$112K |
2013 Q2
7 quarters
|
|
|
HEOP
7
DELISTED
Heritage Oaks Bancorp
HEOP
| $2.29M | 1.52% |
275,000
| – | – |
2013 Q2
7 quarters
|
|
8
Alnylam Pharmaceuticals
ALNY
$30.5B
| $1.96M | 1.31% |
18,750
+8,250
| +79% | +$836K |
2014 Q2
3 quarters
|
|
9
DELISTED
General Motors Company
GM.WS.B
| $1.92M | 1.28% |
97,507
+32,400
| +50% | +$601K |
2013 Q2
7 quarters
|
|
|
PCYC
10
DELISTED
PHARMACYCLICS INC
PCYC
| $1.79M | 1.2% |
7,000
+4,500
| +180% | +$869K |
2014 Q2
3 quarters
|
|
|
LTS
11
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $1.68M | 1.12% |
435,000
| – | – |
2013 Q2
7 quarters
|
|
12
Par Pacific Holdings
PARR
$4.11B
| $1.65M | 1.1% |
70,982
| – | – |
2014 Q3
2 quarters
|
|
13
CALL
Ciena
CIEN
$57.1B
| $1.64M | 1.1% |
+85,000
| New | +$1.69M |
2015 Q1
0 quarters
|
|
14
CALL
Teva Pharmaceutical Industries Limited
TEVA
$47.4B
| $1.56M | 1.04% |
+25,000
| New | +$1.45M |
2015 Q1
0 quarters
|
|
15
CALL
Viatris
VTRS
$20.2B
| $1.48M | 0.99% |
+25,000
| New | +$1.43M |
2015 Q1
0 quarters
|
|
|
FSGI
16
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
| $1.44M | 0.96% |
600,000
| – | – |
2013 Q2
7 quarters
|
|
17
DELISTED
bluebird bio
BLUE
| $1.27M | 0.85% |
811
+186
| +30% | +$245K |
2014 Q3
2 quarters
|
|
|
MLNX
18
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.25M | 0.83% |
27,470
+7,470
| +37% | +$342K |
2014 Q2
3 quarters
|
|
19
Opko Health
OPK
$1.04B
| $1.2M | 0.8% |
85,000
+15,000
| +21% | +$195K |
2013 Q2
7 quarters
|
|
20
Columbia Banking Systems
COLB
$8.08B
| $1.16M | 0.77% |
40,000
-6,000
| -13% | -$165K |
2013 Q2
7 quarters
|
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $1.15M | 0.77% |
+10,000
| New | +$1.19M |
2015 Q1
0 quarters
|
|
22
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.13M | 0.75% |
8,000
-2,000
| -20% | -$308K |
2014 Q2
3 quarters
|
|
|
23
Ciena
CIEN
$57.1B
| $1.06M | 0.71% |
55,000
+20,000
| +57% | +$399K |
2014 Q4
1 quarter
|
|
24
DELISTED
NEVRO CORP.
NVRO
| $1.01M | 0.67% |
21,000
| – | – |
2014 Q4
1 quarter
|
|
|
25
McDonald's
MCD
$166B
| $974K | 0.65% |
+10,000
| New | +$949K |
2015 Q1
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2015 Portfolio in Review
As of Q1 2015, E.E. Geduld held 341 positions worth $150M, down 19% from $186M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
E.E. Geduld withdrew a net $46M in Q1 2015, closing 62 positions and reducing 42 holdings. Its most notable exit was Alibaba, an estimated $2.08M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Celgene Corp worth $1.15M.
- E.E. Geduld's largest Q1 2015 buy was Celgene Corp: 10,000 shares worth $1.15M.
- E.E. Geduld added most to PHARMACYCLICS INC in Q1 2015, an estimated $869K increase.
- E.E. Geduld's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $1.61M.
- E.E. Geduld fully exited Alibaba in Q1 2015, selling an estimated $2.08M.
- E.E. Geduld's ten largest holdings make up 41% of its $150M portfolio in Q1 2015.
- E.E. Geduld opened 79 new positions and closed 62 in Q1 2015.
- E.E. Geduld's portfolio value fell 19% quarter-over-quarter to $150M.
Based on E.E. Geduld's 13F filing for Q1 2015, filed 1 May 2015.